NR4A1 and neoplasm: As tumor recurrence or distant metastasis can occur more than 20 years after primary diagnosis [3] (especially in the hormone receptor-positive setting), early detection of micrometastasis by circulating tumor cell (CTC) analysis through liquid biopsy screenings can help predict patient prognosis and could improve individual treatment [4].